Markus Vettiger
Vorstandsvorsitzender bei Maestrani Schweizer Schokoladen AG
Profil
Markus Vettiger is currently the Chief Executive Officer at Maestrani Schweizer Schokoladen AG since 2006.
He was previously an Independent Director at BioExx Specialty Proteins Ltd.
from 2012 to 2013.
Aktive Positionen von Markus Vettiger
Unternehmen | Position | Beginn |
---|---|---|
Maestrani Schweizer Schokoladen AG
Maestrani Schweizer Schokoladen AG Food: Specialty/CandyConsumer Non-Durables Maestrani Schweizer Schokoladen AG engages in manufacturing of chocolate and cocoa products. It offers chocolate bars, praline and nougat sticks, filled chocolate sticks, seasonal articles, figures and small portions, sugar filled and caramel products. The company is headquartered in Flawil, Switzerland. | Vorstandsvorsitzender | 01.01.2006 |
Ehemalige bekannte Positionen von Markus Vettiger
Unternehmen | Position | Ende |
---|---|---|
BIOEXX SPECIALTY PROTEINS LTD. | Direktor/Vorstandsmitglied | 03.10.2013 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Maestrani Schweizer Schokoladen AG
Maestrani Schweizer Schokoladen AG Food: Specialty/CandyConsumer Non-Durables Maestrani Schweizer Schokoladen AG engages in manufacturing of chocolate and cocoa products. It offers chocolate bars, praline and nougat sticks, filled chocolate sticks, seasonal articles, figures and small portions, sugar filled and caramel products. The company is headquartered in Flawil, Switzerland. | Consumer Non-Durables |
BioExx Specialty Proteins Ltd.
BioExx Specialty Proteins Ltd. BiotechnologyHealth Technology BioExx Specialty Proteins Ltd. engages in the extraction of active ingredients from organic biomasses and inorganic feedstock. It focuses on the extraction of oil and proteins from oilseeds through the use of novel technologies. The company was founded by Christopher Douglas Carl in 2003 and is headquartered in Toronto, Canada. | Health Technology |